THC Biomed Intl (THCBF) Stock Price, News & Analysis

Company Overview

THC Biomed Intl Ltd. is a Canadian cannabis company focused on the cultivation, processing and sale of cannabis products. The company has operated as a licensed cannabis producer in British Columbia and has emphasized small-batch, craft-style production.

Its product activities have included dried cannabis, cannabis plants, seeds and related products for medical and adult-use markets. THC Biomed has also developed cannabis beverages, concentrates, edibles and other cannabis-derived offerings, subject to applicable regulatory requirements.

The company has been associated with operations in Kelowna, British Columbia, and has served Canadian cannabis consumers through regulated distribution channels. Publicly available information about its current operations, leadership and geographic reach is limited, so details may have changed over time.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 7,900 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:THCBF
• CIK: N/A
• Web: thcbiomed.com
• Phone: (844) 842-6337
• Fax: N/A
• Employees: 35
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A